NYSE Parent Company (ticker : FMS)

Transcription

1 Three-Property Medical Portfolio Available for 1031 Exchange NYSE Parent Company (ticker : FMS) LONG-TERM LEASES NEW CONSTRUCTION INVESTMENT-GRADE TENANT Houston, Texas Houston, Texas Bolivar, Missouri 6.07% Initial Cash Flow (3) Newly Constructed Buildings Long-Term Leases () Fresenius is Publicly Traded (NYSE: FMS) Escalating Rental Schedules DST Structure Ideal for 1031 Exchanges KB Exchange Trust provides a cost segregation study prepared by. Utilizing this analysis for accelerated depreciation allows investors to shelter up to 100% of their income for a period of up to 10 years. 1 Bolivar, MO Houston, TX Call Us To Discuss This Investment Opportunity Fresenius Medical Care is the world s largest integrated provider of products and services for individuals undergoing dialysis due to chronic kidney failure. Fresenius is a $25 billion worldwide company with over 105,000 employees and a network of 3,500 dialysis clinics in North America, Europe, Latin America, Asia-Pacific, and Africa. 1 Consult with your tax professional to see how much of your income can be sheltered. Alison Jannotta Director, Investments ajannotta@kingsbarn.com KBXTRUST.com Jeff Farnsworth Executive Vice President jfarnsworth@kingsbarn.com Jeff Pori Managing Partner jpori@kingsbarn.com

2 LEASE SUMMARY Tenant Fresenius Medical Care 1 Lease Term Annual Base Rent (Current) $322, Annual Rent/SF $27.91/SF Lease Commencement April 2016 FRESENIUS - HOUSTON 4901 E. SAM HOUSTON PKWY S HOUSTON, TX Rentable Square Footage: Lot Size: 11, Acres Lease Expiration April 2031 DESCRIPTION: Pasadena is a suburb of Houston, Texas. As of the 2014 census, Pasadena s population was approximately 154,000. Pasadena is part of the Greater Houston metropolitan area, which is the fifth largest metropolitan area in the United States. As of the 2014 census, the Greater Houston metropolitan area has a population of approximately 6.5 million. The City s key economic sectors include exploration for petroleum and gas, maritime shipping, aerospace, and healthcare. Houston is home to 26 Fortune 500 headquarters, ranking third among metro areas. Many other Fortune 500 companies maintain U.S. administrative headquarters in Houston. The Fresenius Medical Care property is ideally located on Sam Houston Parkway. The Kindred Hospital - Bay Area, a 74-bed medical facility, is located directly across from this Fresenius clinic. LEASE YEARS ANNUAL RENT Years 1 $322, Years 2 $322, Years 3 $322, Years 4 $322, Years 5 $322, Years 6 $355, Years 7 $355, Years 8 $355, Years 9 $355, Years 10 $355, Years 11 $390, Years 12 $390, Years 13 $390, Years 14 $390, Years 15 $390, Term Remaining on Lease Renewal Options Increases Property Taxes Insurance Utilities HVAC Roof & Structure 2 14 Years Three 5-Year Options 10% Every 5 Years Landlord Responsibility (1) Guarantor is Fresenius Medical Care Holdings, a wholly-owned subsidiary of Fresenius Medical Care. (2) 20-year roof warranty

3 LEASE SUMMARY Tenant Fresenius Medical Care 1 Lease Term Annual Base Rent (Current) $220, Annual Rent/SF $26.45/SF Lease Commencement June 2016 FRESENIUS - HOUSTON 4625 CENTER STREET HOUSTON, TX Rentable Square Footage: Lot Size: 8, Acres Lease Expiration May 2031 DESCRIPTION: Deer Park is a suburb of Houston, Texas. Houston is the most populous city in Texas and the fourthmost populous city in the United States. It is renowned as an epicenter to some of the most prominent patient-care institutions, such as Baylor St. Luke s Medical Center, MD Anderson Research Medical Library and Cancer Center, and Shriner s Childrens Hospital, as well as academic and medical research institutions. According to the U.S. Bureau of Economic Analysis Greater Houston s gross area product in 2014 was $525 billion. Houston is home to 26 Fortune 500 headquarters, ranking third among metro areas. Many other Fortune 500 companies maintain U.S. administrative headquarters in Houston. The Fresenius Medical Care property features excellent visibility and easy access. The property is located just off the Pasadena Freeway, in the heart of Deer Park. The Bayshore Medical Center, a 345-bed medical facility, is also located 10 minutes from this Fresenius clinic. LEASE YEARS ANNUAL RENT Years 1 $220, Years 2 $220, Years 3 $220, Years 4 $220, Years 5 $220, Years 6 $242, Years 7 $242, Years 8 $242, Years 9 $242, Years 10 $242, Years 11 $266, Years 12 $266, Years 13 $266, Years 14 $266, Years 15 $266, Term Remaining on Lease Renewal Options Increases Property Taxes Insurance Utilities HVAC Roof & Structure Years Three 5-Year Options 10% Every 5 Years Landlord Responsibility (1) Guarantor is Fresenius Medical Care Holdings, a wholly-owned subsidiary of Fresenius Medical Care. (2) 20-year roof warranty

4 LEASE SUMMARY Tenant Fresenius Medical Care 1 Lease Term Annual Base Rent (Current) $272, Annual Rent/SF $33.45/SF Lease Commencement February 2017 FRESENIUS - BOLIVAR 2101 W. BROADWAY ST. BOLIVAR, MO Rentable Square Footage: Lot Size: 8, Acres Lease Expiration February 2032 Kansas City MISSOURI 13 Bolivar 65 Springfield Fresenius Medical Care BOLIVAR COUNTY DIALYSIS DESCRIPTION: Located in the heart of southwest Missouri Bolivar is 30 miles north of Springfield, Missouri. It is the county seat of Polk County and is part of the Springfield, Missouri Metropolitan Statistical Area which had an estimated population of 544,000 as of the 2016 census. Bolivar is one of the best towns in Missouri for young families based on public schools, affordability, income, and growth. 3 The Citizens Memorial Hospital (CMH), an 86-bed medical center, is located two miles from this Fresenius dialysis property St. Louis LEASE YEARS ANNUAL RENT Years 1 $272, Years 2 $276, Years 3 $281, Years 4 $286, Years 5 $291, Years 6 $296, Years 7 $301, Years 8 $306, Years 9 $311, Years 10 $316, Years 11 $322, Years 12 $327, Years 13 $333, Years 14 $339, Years 15 $344, Term Remaining on Lease Renewal Options Increases Property Taxes Insurance Utilities HVAC Roof & Structure 2 Three 5-Year Options 1.7% Annually Landlord Responsibility (1) Guarantor is Fresenius Medical Care Holdings, a wholly-owned subsidiary of Fresenius Medical Care. (2) 20-year roof warranty (3) Survey of 84 Missouri cities with a population of greater than 10,000 (NerdWallet.com)

5 BIG NEWS FROM Standard & Poor s Upgrades Fresenius Medical Care s Credit Rating to Investment Grade January 19, 2015 Bad Homburg, Germany Fresenius Medical Care AG & Co. KGaA (the company or Fresenius Medical Care ; Frankfurt Stock Exchange: FME / New York Stock Exchange: FMS), the world s largest provider of dialysis products and services, today announced that Standard & Poor s has upgraded the corporate credit rating of Fresenius Medical Care from BB+ to BBB- with a stable outlook. The company s financial policy remains unchanged. Fresenius Medical Care will continue to focus on the execution of the long-term strategy introduced in early BB+ BBB- FMS CREDIT RATING Investment Grade Outlook: Stable FRESENIUS BY THE NUMBERS Worldwide Provider of Dialysis Products and Services #1 Year Founded 1912 Market Capitalization $24.66 Billion (as of 2/7/17) Global Fortune 500 Ranking 283 Total Dialysis Clinics (worldwide) 3,579 Patients (worldwide) 286,312 Number of Employees (worldwide) 108,000 (approx)

6 IN THE NEWS FMC Expects Revenue to Almost Double by 2020 Fresenius Medical Care Lifts 2016 Profit Guidance Published: April 3, 2014 Published: October 29, 2015 Fresenius Medical Care Shares Rise as Earnings Beat Forecasts Published: August 2, 2016 Dialysis specialist Fresenius Medical Care said it expected sales to almost double to $28 billion by 2020, driven by growing patient numbers and as it aims to widen its services to medical fields related to kidney failure. The target is equivalent to an average annual increase of about 10 percent from $14.6 billion last year, the world s largest dialysis company said in presentation slides shown on its website on Thursday as part of its capital markets day. The shares extended gains on the news and traded 3.5 percent higher at 1507 GMT. The number of global dialysis patients is set to grow by 6.3 percent per year through 2020, after a 6.8 percent average annual gains over the past 13 years, FMC estimates. FMC is also banking on medical insurers to increasingly pay it for coordinating a range of treatments beyond dialysis. U.S. state-run insurer Medicare has started switching to no longer paying for individual services and drugs and instead to making lumpsum reimbursements per dialysis session, creating incentives for clinic operators to use drugs sparingly and renegotiate procurement prices. FMC expects private insurers in the United States to expand such models to include the treatment of conditions that are linked to dialysis, such as infections of the injection site. FMC believes it is better placed than its smaller rivals to adapt to such systems... FRANKFURT--German health care group Fresenius SE & Co. KGaA (FRE. XE) on Thursday said a good third quarter and continuing strong results at its Fresenius Kabi unit in North America allowed it to raise its net profit guidance for the third time this year. Fresenius now expects net profit to be some 20% to 22% higher than the year-earlier figure of billion euros ($1.20 billion). Under its last guidance raised in July--for the second time this year after April--it had forecast an 18% to 21% profit increase. Fresenius also targets 2015 sales growth of 8% to 10% over the 2014 figure of EUR23.2 billion, unchanged from its previous guidance. The Kabi unit, the group s clinical technology provider, also raised its guidance. It now forecasts an 8% rise in sales, at the upper end of its previous 6% to 8% guidance, and EBIT growth of 19% to 22%, up from the previously targeted 18% to 21%. All company forecasts are in constant currency. In the quarter from July to September, net profit rose 31% to EUR367 million, helped by a tailwind from the positive foreign exchange translation effects of the weak euro, beating a forecast EUR348 million. Sales rose 16% to EUR6.94 billion from EUR5.98 billion in the same quarter a year ago, below the forecast EUR6.95 billion As a result of the weakening of the euro against the U.S. dollar and other major currencies, group sales and profit benefited strongly... American depository shares in Fresenius Medical Care (FMS) rose in pre-market trading after the dialysis specialist beat second-quarter earnings expectations. The stock was up 2.1% at $46.61 before the opening bell in New York. The company, which is 30.9% owned by Fresenius SE, posted revenue of $4.42 billion, up 5% year-on-year but marginally below analysts expectations in the second quarter. Ebit and earnings-per-share were 2% and 4% higher, respectively, than analysts consensus forecast, according to Jefferies analyst Chris Cooper. The group s second-quarter net profit rose 22% to $294 million. The company derived about three-quarters of second-quarter revenue from North America, where it bolstered margins in the period. The Bad Homburg vor der Hohe, Germany company also reiterated its full-year forecast for 7% to 10% revenue growth and a 15% to 20% increase in net profit based on current exchange rates. Net profit in the first half rose 16%, after 9% growth in the first-quarter, putting it at the low end of that full-year forecast rate, Cooper noted. Fresenius Medical Care announced its figures at around the same time as Fresenius SE, a diversified health care group which operates hospitals and sells medical equipment and treatments. Fresenius quarterly sales came in 2% short of expectations after its Kabi division was hit by currency fluctuations. Sales were 7.09 billion... *Source: *Source: *Source:

7 This Fresenius Medical Care portfolio is being sold with a Delaware Statutory Trust (DST) ownership structure in place. It is, therefore, eligible as a 1031 exchange. About DSTs A Delaware Statutory Trust (DST) is a separate legal entity created as a trust under Delaware statutory law. Delaware law provides great flexibility in the design and operation of the entity. However, to use a DST in a Section 1031 tax-deferred exchange program, it must comply with the requirements of IRS Revenue Ruling so that a beneficial interest in the trust is treated as a direct interest in real estate for tax purposes. The trust also must satisfy lender requirements, especially if the loan is to be securitized. A DST-structure is a pooled-equity investment. DST purchasers realize significant benefits by acquiring a property that is typically a higher-quality asset than could be purchased individually. Investors looking for stabilized, core properties often favor a DSTstructured investment. Simplified 1031-Exchange Solution Purchasers of DST-structured real estate investments typically enjoy monthly cash flow from high quality properties. A KB Exchange Trust DST investment affords purchasers an investment free of day-to-day management responsibilities as KB Exchange Trust and its third-party management partners professionally conduct all property and asset management. KB Exchange Trust facilitates the entire transaction: n Identifying the real property n Professional due diligence reports n Securing financing (non-recourse to DST Investors) n Coordinating with qualified intermediaries n Providing all organizational and offering documentation n Providing a legal Tax Opinion n Professional third-party property and asset management services n Monthly check issuance to investors (by check or direct-deposit)

8 INVESTMENT SUMMARY Offering Price: $15,520,000 Cap Rate: 6.04% Net Operating Income (Year 1): $815,716 Lease Terms: Monthly Rent Per Sq. Ft.: $2.42 Total Rentable Sq. Ft.: 28,045 EQUITY INVESTMENTS STARTING FROM $100, CENTER STREET DEER PARK, TX ABOUT KB EXCHANGE TRUST KB Exchange Trust is an affiliate of Kingsbarn Realty Capital, an experienced national commercial real estate firm. KB Exchange Trust provides real estate investors with 1031-exchange eligible property ownership through its Delaware Statutory Trust ( DST ) program. The principals of KB Exchange Trust have acquired over $2 billion of commercial properties over the past 10 years. A KB Exchange Trust DST investment affords purchasers an investment free of day-to-day management responsibilities as KB Exchange Trust and its third-party management partners professionally conduct all property and asset management. KB EXCHANGE TRUST FINANCING - NEW FIRST MORTGAGE Loan Amount: $8,785,000 Loan-to-Value: 65% Loan-to-Cost: 56.64% Interest Rate: 4.64% Loan Term (Months): 120 Interest-Only Period (Months): 60 Monthly Loan Payments: $33,969 Annual Loan Payments: $407, E. SAM HOUSTON PKWY S PASADENA, TX ESTIMATED YEAR 1 PRE-TAX CASH FLOW $408,092 ESTIMATED YEAR 1 CASH-ON-CASH RETURN 6.07% MINIMUM EQUITY PURCHASE $100,000 PRICE PER EACH 1% INTEREST $67,250 FRESENIUS MEDICAL CARE AT-A-GLANCE 2101 W. BROADWAY BOLIVAR, MO Typical Fresenius Interior As a vertically-integrated company, Fresenius Medical Care offers products and services along the entire dialysis value chain from a single source. FMC cares for more than 300,000 patients in their global network of 3,500 dialysis clinics. At the same time, they operate more than 40 production sites on all continents, making them the world s leading provider of dialysis products such as dialysis machines dialyzers, and related disposable accessories. This brochure is not an offer to sell, or a solicitation of an offer to buy, securities. Offers can only be made through the Private Placement Memorandum. DST Units may be sold only to accredited investors, as defined in Regulation D under the U.S. Securities Act of 1933, as amended (the Securities Act ), which, for natural persons, refers to investors who meet certain minimum annual income or net worth thresholds. DST Units are being offered in reliance on an exemption from the registration requirements of the Securities Act and the laws of any U.S. State or non-u.s. jurisdiction, and are not required to comply with specific disclosure requirements that apply to registration under the Securities Act. Neither the U.S. Securities and Exchange Commission nor any other regulatory authority has passed upon the merits of an investment in the DST Units, has approved or disapproved of the DST Units or passed upon the accuracy or adequacy of the offering materials describing the securities. The securities are subject to legal restrictions on transfer and resale in accordance with the governing documents of the Delaware Statutory Trust and applicable securities laws, and investors may be unable to sell or transfer their DST Units. In addition, there is no public market for the DST Units and no such market is expected to develop in the future. Investing in the DST Units involves risk, and investors should be able to bear the loss of their investment. This brochure does not purport to be complete and should be viewed in conjunction with the Private Placement Memorandum. An investment of this sort is speculative and involves a high degree of risk. Projections of future performance contained herein are based on specific assumptions discussed more fully in the Private Placement Memorandum and do not constitute a guaranty of future performance.